Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial DoseLeil, T A; Feng, Y; Zhang, L; Paccaly, A; Mohan, P; Pfister, M · 2010

Model-Based Exposure–Response Analysis of Apixaban to Quantify Bleeding Risk in Special Populations of Subjects Undergoing Orthopedic SurgeryLeil, T A; Frost, C; Wang, X; Pfister, M; LaCreta, F · CPT Pharmacometrics Syst. Pharmacol. · 2014

Evaluation of 4β-Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism–Based Pharmacometric ModelLeil, T A; Kasichayanula, S; Boulton, D W; LaCreta, F · CPT Pharmacometrics Syst. Pharmacol. · 2014

Modeling and Simulation of Count DataPlan, E L · CPT Pharmacometrics Syst. Pharmacol. · 2014

Clinical Translation in the Virtual Liver NetworkKuepfer, L; Kerb, R; Henney, A M · CPT Pharmacometrics Syst. Pharmacol. · 2014

Visualization and Communication of Pharmacometric Models With Berkeley MadonnaKrause, A; Lowe, P J · CPT Pharmacometrics Syst. Pharmacol. · 2014

Predicting QTc Prolongation in Man From Only In Vitro DataLeishman, D J · CPT Pharmacometrics Syst. Pharmacol. · 2014

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug DevelopmentMaharaj, A R; Edginton, A N · CPT Pharmacometrics Syst. Pharmacol. · 2014

Introduction to Population Pharmacokinetic/Pharmacodynamic Analysis With Nonlinear Mixed Effects ModelsGraaf, P H van der · CPT Pharmacometrics Syst. Pharmacol. · 2014

Implementation of Quantitative and Systems Pharmacology in Large PharmaVisser, S A G; de Alwis, D P; Kerbusch, T; Stone, J A; Allerheiligen, S R B · CPT Pharmacometrics Syst. Pharmacol. · 2014

Translation of Anticancer Efficacy From Nonclinical Models to the ClinicStroh, M; Duda, D G; Takimoto, C H; Yamazaki, S; Vicini, P · CPT Pharmacometrics Syst. Pharmacol. · 2014